UBS Reiterates Neutral Rating on Myriad Genetics (MYGN)
Go back to UBS Reiterates Neutral Rating on Myriad Genetics (MYGN)| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 4.48 -0.15 (3.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.63 | 52 Week High | $45.34 | |||
| Open | $4.63 | 52 Week Low | $15.92 | |||
| Day High | $4.67 | P/E | 1.92 | |||
| Day Low | $4.41 | EPS | $2.33 | |||
| Volume | 217,094 | |||||
